Aurobindo Pharma Q2 net profit up 26% to ₹805.65 crore

  • Consolidated total revenue from operations during the period under review stood at 6,483.44 crore
  • The company said it received final approval for 10 ANDAs (abbreviated new drug applications) from USFDA

PTI
Updated11 Nov 2020, 10:03 PM IST
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd(Mint)

Aurobindo Pharma Ltd on Wednesday reported a 26% increase in consolidated net profit at 805.65 crore in the second quarter ended September.

The company had posted a consolidated net profit of 639.53 crore in the same quarter last fiscal, Aurobindo Pharma said in a regulatory filing.

Consolidated total revenue from operations during the period under review stood at 6,483.44 crore as against 5,600.47 crore in the corresponding quarter last fiscal, it added.

Commenting on the company's performance Aurobindo Pharma Managing Director N Govindarajan said: "We continue to perform well across all our key geographies and segments to report a consistent set of earnings."

He further said: "On our endeavour towards our differentiated products basket, we are happy to state that we have completed phase I clinical trials for our first biosimilar and started trials for three more products. We reiterate that we are committed to resolving all pending regulatory issues."

During the second quarter, the company said its US formulation revenue stood at 3,189.8 crore as against 2,835.5 crore in same period last fiscal, a growth of 12.5%, while Europe formulation revenue was at 1,514.8 crore, a growth of 8.1% from the year-ago quarter.

The company said it received final approval for 10 ANDAs (abbreviated new drug applications) from USFDA.

Its board has also approved a second interim dividend of 125% at 1.25 per equity share of Re 1 for the financial year 2020-21.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.MoreLess
First Published:11 Nov 2020, 10:03 PM IST
HomeCompaniesCompany ResultsAurobindo Pharma Q2 net profit up 26% to ₹805.65 crore

Most Active Stocks

Indian Oil Corporation

174.50
03:59 PM | 11 JUL 2024
2.55 (1.48%)

Tata Steel

169.00
03:58 PM | 11 JUL 2024
1 (0.6%)

Bharat Petroleum Corporation

306.60
03:59 PM | 11 JUL 2024
6.25 (2.08%)

Oil & Natural Gas Corporation

304.80
03:57 PM | 11 JUL 2024
6.75 (2.26%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Gujarat Pipavav Port

236.60
03:44 PM | 11 JUL 2024
16.85 (7.67%)

Oil India

551.45
03:41 PM | 11 JUL 2024
38.7 (7.55%)

Great Eastern Shipping Company

1,460.00
03:29 PM | 11 JUL 2024
98.25 (7.21%)

Mazagon Dock Shipbuilders

5,739.10
03:48 PM | 11 JUL 2024
383.7 (7.16%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    73,705.000.00
    Chennai
    74,722.000.00
    Delhi
    73,705.000.00
    Kolkata
    74,722.000.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L0.00
    Chennai
    100.75/L0.00
    Kolkata
    104.95/L0.00
    New Delhi
    94.72/L0.00
    OPEN IN APP
    HomeMarketsCibilPremiumMint Shorts